Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Neuroendocrine

Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.

230 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Neuroendocrine trial results

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

NCT02893930

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +18 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • PCR Oncology Arroyo Grande, California, United States
View all 405 locations
View Trial Details
Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Hematology Oncology Associates of Illinois - Berwyn Berwyn, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
  • Midwest Center for Hematology/Oncology Joliet, Illinois, United States
View all 112 locations
View Trial Details
Completed

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

NCT02267603

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Merkel Positron Emission Tomography (PET) Protocol

NCT01013779

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Campbelltown Campbelltown, New South Wales, Australia
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Royal Prince Alfred Sydney, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
View all 13 locations
View Trial Details

Related conditions